White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome

Brain

Volumn 133, Issue 12, 2010, Pages 3676-3684

  Stepens, Ainars ^a   Stagg, Charlotte Jane ^b,c   Platkajis, Ardis ^a   Boudrias, Marie Hélène ^c   Johansen Berg, Heidi ^b,c   Donaghy, Michael ^b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

diffusion imaging; extrapyramidal syndrome; manganese toxicity; methcathinone; white matter tracts

Indexed keywords

METHCATHINONE;

ADULT; AKINESIA; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; DISABILITY; DISEASE SEVERITY; DRUG ABUSE; EXTRAPYRAMIDAL SYNDROME; FEMALE; FRACTIONAL ANISOTROPY; GLOBUS PALLIDUS; HUMAN; MALE; MOTOR PERFORMANCE; NEUROIMAGING; NUCLEUS ACCUMBENS; OUTCOME ASSESSMENT; PREMOTOR CORTEX; PRIORITY JOURNAL; PYRAMIDAL TRACT; RIGIDITY; TREMOR; WHITE MATTER;

EID: 78649888123     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq281     Document Type: Article

References (44)

1. Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004; 8: 170-7.
2. Assaf Y. Can we use diffusion MRI as a bio-marker of neurodegenerative processes? BioEssays 2008; 30: 1235-45.
3. Assaf Y, Blumenfeld-Katzir T, Yovel Y, Basser PJ. Axcaliber: a method for measuring axon diameter distribution from diffusion MRI. Magn Reson Med 2008; 59: 1347-54.
4. Beaulieu C. The biological basis of diffusion anisotropy. In: Johansen-Berg H, Behrens TEJ, editors. Diffusion MRI: From quantitative measurement to in-vivo neuroanatomy. London: Elsevier; 2009. p. 105-26.
5. Behrens T, Johansen-Berg H, Jbabdi S, MFS R, Woolrich M. Probabilistic diffusion tractography with muleipl fibre orientations. What can we gain? Neuroimage 2007; 23: 144-55.
6. Behrens T, Woolrich M, Jenkinson M, Johansen-Berg H, Nunes R, Clare S, et al. Characterization and propogation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003; 50: 1077-88.
7. Buch ER, Mars RB, Boorman ED, Rushworth MFS. A network centered on ventral premotor cortex exerts both facilitatory and inhibitory control over primary motor cortex during action peprogramming. J Neurosci 2010; 30: 1395-401.
8. Cavina-Pratesi C, Valyear KF, Culham JC, Kohler S, Obhi SS, Marzi CA, et al. Dissociating arbitrary stimulus-response mapping from movement planning during preparatory period: evidence from event-related functional magnetic resonance imaging. J Neurosci 2006; 26: 2704-13.
9. Chan L-L, Rumpel H, Yap K, Lee E, Loo H-V, Ho G-L, et al. Case control study of diffusion tensor imaging in Parkinson's Disease. J Neurol Neurosurg and Psychiatry 2007; 78: 1383-6.
10. Colosimo C, Guidi M. Parkinsonism due to ephedrone neurotoxicity: a case report. Eur J Neurol 2009; 16: e114-5.
11. De Bie R, Gladsonte R, Strafella A, Ko J, Lang A. Manganese-induced Parkinsonism associated with methcathinone (ephedrone) abuse. Arch Neurol 2007; 64: 886-9.
12. Draganski B, Kherif F, Klappel S, Cook P, AlexanDer D, Parker G, et al. Evidence for segregated and integrative connectivity patterns in the human basal ganglia. J Neurosci 2008; 28: 7143-52.
13. Emmerson T, Cisek J. Methcathinone: a russian designer amphetamine infiltrates the rural midwest. Ann Emerg Med 1993; 22: 1897-903.
14. Fahn S, Marsden C, Calne DB. Recent developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987.
15. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. Am J Neuroradiol 2009; 30: 1222-6.
16. Gongvatana A, Schweinsburg B, Taylor M, Theilmann R, Letendre S, Alhassoon O, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus infected individuals. J Neurovirol 2009; 15: 187-95.
17. Guilarte T, Burton N, Verina T, Prabhu V, Becker K, Syversen T, et al. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J Neurochem 2008; 105: 1948-59.
18. Guilarte T, McGlothan J, Degaonkar M, Chen M-K, Barker P, Syversen T, et al. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci 2006; 94: 351-8.
19. Jenkinson M, Bannister P, Brady J, Smith S. Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825-41.
20. Johansen-Berg H, Della-Maggiore V, Behrens TEJ, Smith SM, Paus T. Integrity of white matter in the corpus callosum correlates with biman-ual co-ordination skills. Neuroimage 2007; 36: T16-21.
21. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. Am J Neuroradiol 2008; 29: 501-5.
22. Levin O. "Ephedron" encephalopathy. Zh Nevrol Psikhitr Im S S Korsakova 2005; 105: 12-20 (in Russian).
23. Mars R, Klein M, Neubert F, Olivier E, Buch E, Boorman E, et al. Short-latency influence of medial frontal cortex on primary motor cortex during action selection unDer conflict. J Neurosci 2009; 29: 6926-31.
24. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cognition 2000; 42: 183-200.
25. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Dis 1998; 13: 684-9.
26. Mostofsky SH, Simmonds DJ. Response inhibition and response selection: two sides of the same coin. J Cogn Neurosci 2008; 20: 751-61.
27. Nachev P, Wydell H, O'Neill K, Husaim M, Kennard C. The role of the pre-supplementary motor area in the control of action. Neuroimage 2007; 36: 115-63.
28. Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129: 2679-87.
29. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ, et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996; 46: 492-8.
30. Perl DP, Olanow CW. The neuropathology of manganese-induced Parkinsonism. J Neuropath Exp Neurol 2007; 66: 675-82.
31. Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S. Manganic encephalopathy due to "ephedrone" abuse. Movement Dis 2007; 22: 1337-43.
32. Schocke MF, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002; 58: 575-80.
33. Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004; 21: 1443-51.
34. Selikhova M, Fedoryshyn L, Matviyenko Y, Komnatska I, Kyrylchuk M, Krolicki L, et al. Parkinsonism and dystonia caused by the illicit use of ephedrone-A longitudinal study. Movement Dis 2008; 23: 2224-31.
35. Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Askmark H, et al. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol Scand 2010; 121: 237-43.
36. Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Zjablov G, et al. Irreversible motor impairment in young addicts - epehdrone, mangan-ism or both? Acta Neurol Scand 2007; 115: 385-9.
37. Smith SM. Fast, Robust automated briain extraction. Hum Brain Mapp 2002; 17: 143-55.
38. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487-505.
39. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens T, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23: S208-19.
40. Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008; 358: 1009-17.
41. Tanaka K, Nogawa S, Suzuki S, Dembo T, Kosakai A. Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. Brain Res 2003; 989: 172-9.
42. Varlibas F, Delipoyraz I, Yuksel G, Filiz G, Tireli H, Gecim N. Neurotoxicity following chronic intravenous use of "Russion cocktail" . Clin Toxicol 2009; 47: 157-60.
43. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004; 75: 481-4.
44. Zingel K, Dovensky W, Crossman A, Allen A. Ephedrone 2-methylamino-1- phenylpropane-1-one (Jeff). J Forensic Sci 1991; 36: 915-20.